Pacira BioSciences' Short-term Investments fell 52.49% to $98.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.7 million, marking a year-over-year decrease of 52.49%. This contributed to the annual value of $207.8 million for FY2024, which is 65.90% up from last year.
Latest data reveals that Pacira BioSciences reported Short-term Investments of $98.7 million as of Q3 2025, which was down 32.08% from $145.4 million recorded in Q2 2025.
Pacira BioSciences' 5-year Short-term Investments high stood at $559.8 million for Q3 2021, and its period low was $70.8 million during Q4 2021.
Moreover, its 3-year median value for Short-term Investments was $141.8 million (2024), whereas its average is $154.8 million.
Its Short-term Investments has fluctuated over the past 5 years, first slumped by 83.20% in 2021, then skyrocketed by 160.50% in 2022.
Quarterly analysis of 5 years shows Pacira BioSciences' Short-term Investments stood at $70.8 million in 2021, then surged by 160.50% to $184.5 million in 2022, then slumped by 32.10% to $125.3 million in 2023, then spiked by 65.90% to $207.8 million in 2024, then slumped by 52.49% to $98.7 million in 2025.
Its Short-term Investments was $98.7 million in Q3 2025, compared to $145.4 million in Q2 2025 and $210.0 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value